AMSTERDAM, October 27, 2015 /PRNewswire/ --
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of NanoImpact, a new multidisciplinary journal that is devoted to publishing cutting edge research addressing the behavior and impact of nanomaterials on human health and environmental systems.
NanoImpact welcomes article submissions in the following four main areas of research: human nanotoxicology, econanotoxicology, exposure, and risk- and lifecycle assessment. Other topics of research such as the development of methodological and modelling approaches and the development of materials and methods to enhance nanosafety, will also be considered if there is a clear link to four main areas. .
The journal will be under the editorship of: Associate Professor Philip Demokritou, Harvard University, USA; Professor Guibin Jiang, State Key Laboratory of Environmental Chemistry and Ecotoxicology, Chinese Academy of Sciences China (CAS); Professor Jamie R. Lead, University of South Carolina, USA and Professor Bernd Nowack, Swiss Federal Laboratories for Materials Science and Technology (Empa), Switzerland.
Deirdre Dunne, Senior Publisher at Elsevier said of the launch, "With increasing attention on the impact of nanomaterials on human health and the environment, NanoImpact will benefit various groups including scientists, governmental and international organizations as well as the general public. The journal embraces and promotes the increasing multidisciplinary nature of the field of nanosafety through publishing high quality themed issues. We believe that it will be a valuable contribution not only to the field, but also the wider academic community."
For more information and to submit an article, go to: http://www.journals.elsevier.com/nanoimpact
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes more than 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. http://www.elsevier.com
+ 31 20 485 3870